Health Care & Life Sciences » Biotechnology | Ampliphi Biosciences Corp.

Ampliphi Biosciences Corp.

Ampliphi Biosciences Corp.
Stock Exchange NYSE
EPS
 $0.74
Market Cap
 $15.89 M
Shares Outstanding
 16.46 M
Public Float
 15.59 M

Profile

Address
3579 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.ampliphibio.com
Updated 09/14/2018
AmpliPhi Biosciences Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company was founded in March 1989 and is headquartered in San Diego, CA.

Financials

View All
Created with Highcharts 5.0.14Ampliphi Biosciences Corp.Net Income. Fiscal year is January-December. All values USD Thousands.55 86155 86123 10923 10951651622 41822 41812 83812 83820132014201520162017010k20k30k40k50k60k
Created with Highcharts 5.0.14Ampliphi Biosciences Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.325325409409475475260260115115201320142015201620170100200300400500

Paul C. Grint
Chief Executive Officer & Director
Wendy S. Johnson
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.